PCI Biotech Holding ASA

    PCI Biotech Holding ASA

    OOSL:PCIB
    - -
    NOK
    - -
    - -
    PCI Biotech Holding ASA
    OSL:PCIB
    (Euronext Oslo)

    Recent

    price

    - -

    P/E

    ratio

    - -

    div

    yld

    - -

    ROIC.AI

    2009
    2010
    2011
    2012
    2013
    2014
    2015
    2016
    2017
    2018
    2019
    2020
    2021
    2022
    2023
    2024
    TTM
    NOK
    0.95
    0.94
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Revenue per Share
    -1.65
    -1.26
    -1.07
    -1.97
    -2.14
    -3.22
    -2.12
    -2.01
    -1.76
    -1.25
    -3.19
    -1.94
    -2.37
    -1.48
    -0.54
    -0.44
    -0.78
    Basic EPS, GAAP
    -1.87
    -0.96
    -1.48
    -1.9
    -2.22
    -2.85
    -2.18
    -2.22
    -1.26
    -1.45
    -2.94
    -2.08
    -1.83
    -1.58
    -0.4
    -0.37
    -0.81
    Free Cash Flow per Basic Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Dividend per Share
    -6.05
    -5.61
    -5.91
    -7.87
    -2.58
    -6.08
    -5.08
    -6.7
    -4.74
    -3.94
    -7.03
    -7.01
    -9.02
    1.54
    0.03
    0.03
    3
    Book Value per Share
    3.86
    9.52
    7.2
    5.43
    3.36
    0.82
    2.94
    0.82
    1.72
    12.23
    9.17
    5.08
    3.05
    1.54
    1.04
    0.63
    1.26
    Tangible Book Value per Share
    9
    11
    13
    13
    13
    11
    15
    16
    24
    28
    28
    37
    37
    37
    38
    37
    37
    Basic Weighted Avg Shares
    9
    10
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Sales/Revenue/Turnover
    -205.36
    -155.52
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Operating Margin (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    1
    2
    3
    6
    - -
    - -
    1
    Depreciation Expense
    -15
    -14
    -14
    -25
    -28
    -36
    -32
    -32
    -43
    -35
    -89
    -72
    -88
    -55
    -20
    -16
    -29
    Net Income, GAAP
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Effective Tax Rate (%)
    -174.35
    -133.47
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Profit Margin (%)
    35
    108
    94
    71
    43
    9
    44
    13
    44
    340
    251
    181
    107
    57
    39
    23
    47
    Working Capital
    - -
    3
    2
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    1
    - -
    1
    - -
    - -
    - -
    - -
    LT Debt
    35
    105
    93
    70
    43
    9
    44
    13
    42
    340
    255
    189
    114
    57
    39
    23
    47
    Total Equity
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Invested Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    -69.43
    -1,467.11
    -8.63
    Return on Common Equity (%)

    Capital Structure

    NOK

    •

    in mil. unless spec.
    Dec'22
    Mar'23
    Jun'23
    ST Debt
    - -
    - -
    - -
    LT Borrowings
    - -
    - -
    - -
    LT Finance Leases
    - -
    - -
    - -
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    37
    37
    37
    Market Capitalization
    77
    77
    79

    Working Capital

    NOK

    •

    in mil. unless spec.
    Dec'22
    Mar'23
    Jun'23
    Total Current Assets
    63
    57
    52
    Cash, Cash Equivalents & STI
    56
    51
    46
    Accounts Receivable, Net
    - -
    6
    6
    Inventories
    - -
    - -
    - -
    Total Current Liabilities
    6
    5
    5
    Payables & Accruals
    - -
    - -
    - -
    ST Debt
    - -
    - -
    - -
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    NOK

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    103.56%
    -37.41%
    -39.93%
    Free Cash Flow
    1.94%
    -22.66%
    -8.1%
    Net Income, GAAP
    4.31%
    -23.25%
    -19.19%
    Sales/Revenue/Turnover
    - -
    - -
    - -
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    NOK

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    - -
    - -
    - -
    - -
    - -
    2024
    - -
    - -
    - -
    - -
    - -
    2025
    - -
    - -
    - -
    - -
    - -

    Quarterly Earnings Per Share

    NOK

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    -0.16
    -0.15
    - -
    - -
    -0.54
    2024
    - -
    - -
    - -
    - -
    -0.44
    2025
    - -
    - -
    - -
    - -
    - -

    Quarterly Dividends Per Share

    NOK

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    - -
    - -
    - -
    - -
    - -
    2024
    - -
    - -
    - -
    - -
    - -
    2025
    - -
    - -
    - -
    - -
    - -
    Similar Companies
    Business